Cerner Corporation Stock News

Cerner Corp. (CERN) shares closed today at 1.3% below its 52 week high of $93.44, giving the company a market cap of $27B. The stock is currently down 0.7% year-to-date, up 16.3% over the past 12 months, and up 85.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 62.3% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -47.0% The company's stock price performance over the past 12 months beats the peer average by 22.4% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -354.0% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cerner Corporation (NASDAQ: CERN ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Oracle Corporation for $95.00 per share. If you are a Cerner shareholder, click here to learn more about your rights and options . Lawson Products, Inc. (NASDAQ: LAWS ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with TestEquity and Gexpro Full story available on Benzinga.com

Oracle: Solid Q2 Report, But Cerner Acquisition Adds Some Complexity

Cerner Corp. (CERN) shares closed today at 1.2% below its 52 week high of $93.44, giving the company a market cap of $27B. The stock is currently down 0.6% year-to-date, up 17.3% over the past 12 months, and up 100.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 44.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Information Technology industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -75.3% The company's stock price performance over the past 12 months beats the peer average by 35.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -360.6% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Dublin, Jan. 07, 2022 (GLOBE NEWSWIRE) -- The "Digital Health Market, By Product & Service (mHealth and eHealth), Component (Software, Hardware and Services) and End User (Healthcare providers, Payers, Healthcare Consumer and Others) . - Global Forecast to 2027" report has been added to ResearchAndMarkets.com''s offering. According to this report the total market is expected to grow at a CAGR of 16.3% during the forecast period from 2021 to 2027. This report covers a sub-market in this field - the Digital Health Market by component in detail, segmenting the market as mhealth and ehealth. Component segment includes software, hardware and services. It provides in-sights on end user that segregates into healthcare providers, payers, healthcare consumer and others. Lastly, the Digital Health Market is segmented by geography across North America, Europe, Asia-Pacific (APAC), ROW (Rest of the World) and regional market further sub-segmented by countries. The report deals with all the driving factors, opportunities, and challenges with respect to the global Digital Health Market, which are helpful in identifying trends and key success factors for the industry.

TORONTO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the "Company" or "VitalHub") (TSX: VHI ) is pleased to announce a significant licensing transaction of subsidiary Intouch with Health''s ("Intouch") patient flow platform to Royal Berkshire NHS Foundation Trust (the "Trust" or "Royal Berkshire"). In November 2021, Royal Berkshire secured central funding to support the Trust''s digital transformation and digitization of health and care systems. The transaction is principally focused on Royal Berkshire Hospital and allows the licensed solutions to be used at all 6 Trust sites. This deal comes as a result of the Trust having identified a need for a platform which would enable a longer term objective to digitally transform outpatient coordination. VitalHub successfully demonstrated proficiency in the technologies required to support the need for a multi-faceted patient journey solution. The Trust purchased the following Intouch modules from VitalHub; Flow Manager, Self-Check-In, Mobile Appointment Manager, Patient Calling, Wait Time Manager, Activity Manager, and HL7 Integration with Cerner, thus meeting the Trust''s criteria to work with a technology provider capable of offering digital solutions across the whole of outpatients and not just a point solution.

Dublin, Jan. 04, 2022 (GLOBE NEWSWIRE) -- The "Global Market for Digital Health Technologies 2021-2026" report has been added to ResearchAndMarkets.com''s offering.

It is advisable to follow broker rating upgrades for robust returns. Hence, we pick Boston Beer (SAM), Williams-Sonoma (WSM), Cerner (CERN), PNM Resources (PNM) and Sonoco (SON) as these witness ratin

Key Players Covered In Connected Healthcare Market Research Report Are Allscripts Healthcare, Cerner Corporation, Koninklijke Philips N.V, McKesson Corporation, Apple Inc., Omron Corporation, GENERAL ELECTRIC COMPANY, Fitbit Inc., IBM Corporation, NXGN Management, LLC Key Players Covered In Connected Healthcare Market Research Report Are Allscripts Healthcare, Cerner Corporation, Koninklijke Philips N.V, McKesson Corporation, Apple Inc., Omron Corporation, GENERAL ELECTRIC COMPANY, Fitbit Inc., IBM Corporation, NXGN Management, LLC

NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Shares of Oracle Corp. slipped 0.3% in afternoon trading Friday, putting them on track to extend their losing streak to 11 sessions. That would be the longest such streak since Oracle went public in March 1986, according to Dow Jones Market Data. The database giant''s stock has now tumbled 15.3% since it last gained ground, when it rose 3.8% on Dec. 15 to close at a record $103.65. Highlighting the losing streak was the 11.2% drop in two days to Dec. 20, after The Wall Street Journal reported, and Oracle confirmed, that it agreed to buy medical-records company Cerner Corp. in a deal valued at $28.3 billion. Despite the record-long losing streak, Oracle''s stock has still run up 35.7% this year, while the SPDR Technology Select Sector ETF has climbed 34.1% and the S&P 500 has advanced 27.3%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

If history is any guide, there may be good fortune ahead for shares of Cerner (NASDAQ: CERN ). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions. When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending higher. If the short-term average price crosses below the long-term Full story available on Benzinga.com

Oracle gets into healthcare tech with its record-setting planned acquisition of Cerner for $28 billion in cash.

Oracle's (ORCL) debt profile could further deteriorate if the company takes up more debt to finance Cerner acquisition and that could lead to possible rating downgrades, noted Bloomberg.